Insiders Vera Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:05 17/05/2024 am IST			5-day change	1st Jan Change
41.98 ^USD	-1.65%		-6.58%	+172.98%

10/05	Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating	MT
09/05	Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Vera Therapeutics Insider Bought Shares Worth $4,999,990, According to a Recent SEC Filing	02/02	MT
Vera Therapeutics, Inc. Announces Executive Changes	08/01	CI
Vera Therapeutics Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs	04/23/04	CI
Insider Buy: Vera Therapeutics	31/23/31	MT
Insider Buy: Vera Therapeutics	22/23/22	MT
Insider Buy: Vera Therapeutics	15/23/15	MT
Insider Buy: Vera Therapeutics	04/23/04	MT
Insider Buy: Vera Therapeutics	10/23/10	MT
Insider Sell: Vera Therapeutics	15/22/15	MT
Insider Sell: Vera Therapeutics	21/22/21	MT
Insider Sell: Vera Therapeutics	06/22/06	MT
Insider Sell: Vera Therapeutics	23/22/23	MT
Insider Sell: Vera Therapeutics	15/22/15	MT
Insider Sell: Vera Therapeutics	10/22/10	MT
Insider Sell: Vera Therapeutics	07/22/07	MT
Insider Sell: Vera Therapeutics	24/22/24	MT
Insider Sell: Vera Therapeutics	16/22/16	MT
Insider Sell: Vera Therapeutics	21/22/21	MT
Insider Sell: Vera Therapeutics	16/22/16	MT
Vera Therapeutics Appoints Michael Morrissey as Chairman of Board	12/22/12	MT

No results for this search